Search bioRxivSearch

bioRxiv · 10.64898/2026.08.28.747811

MIND the gap: methodological considerations and guidance for structural MRI similarity network analysis with MIND

Abstract

Structural similarity networks quantify the similarity of structural properties across cortical regions, providing a macroscopic window onto the organisation of cortical architecture. Morphometric inverse divergence (MIND) is a multivariate metric of similarity between cortical areas, based on the Kullback-Leibler (KL) divergence between areal distributions of multiple MRI features or morphometric variables locally measured at voxel or vertex resolution. MIND has demonstrated technical robustness and biological validity and is increasingly widely used as a measure of cortico-cortical similarity in clinical and developmental network neuroscience. Here we provide in-depth methodological background on KL divergence and MIND, highlighting possible sources of bias, critical user decision points in the design of a MIND processing pipeline, and recommendations for technical risk mitigation in using MIND as a metric of cortical similarity. We use simulated data and observational MRI datasets from adults (UK Biobank, N = 500 T1-weighted and diffusion scans) and neonates (Developing Human Connectome Project, N = 752 T2-weighted scans), to show how the estimator of KL divergence implemented in MIND is potentially influenced or biased by five properties of input MRI feature maps: (i) their smoothness; (ii) the proportion of identical values; (iii) analysis in native or common space and the choice of vertex mesh resolution; (iv) parcellation choice; and (v) covariance between input features. We offer principled and practical guidance for investigators wanting to specify and implement the MIND processing pipeline that is best suited to the constraints and opportunities of the MRI data available to them. These recommendations outline which pipeline steps should be used sparingly, such as vertex map smoothing; which should be used with informed caution, such as parcellation choice or vertex mesh resampling; and which could be newly implemented for more robust estimation of MIND, such as the use of principal component analysis to preprocess multivariate MRI features. To support further development of structural MRI similarity network analysis, and wider adoption of robust MIND methods, we also publish the code used to generate the results in this paper as an open resource.

Explore related subjects

Keep this discovery

BibTeXRIS

Davies, A., Hutchings, E., Chidiac, B., Garvey, M., Crockford, S., Sebenius, I., Bethlehem, R. A. I., Bullmore, E., Morgan, S.. 2026-09-03. MIND the gap: methodological considerations and guidance for structural MRI similarity network analysis with MIND. https://doi.org/10.64898/2026.08.28.747811

Cite the original work for its findings. Save a collection to share your selection of sources.

Discover connections

Connections use source metadata and explicit phrase matches, not verified experimental comparisons.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience